Header Logo

Connection

THOMAS TAYLOR to Antiviral Agents

Back to Details
This is a "connection" page, showing publications THOMAS TAYLOR has written about Antiviral Agents.
THOMAS TAYLOR
Connection Strength
0.136
Antiviral Agents
  1. Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022; 17(2):e0263591.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.